1. Home
  2. CLW vs SGHT Comparison

CLW vs SGHT Comparison

Compare CLW & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$13.64

Market Cap

216.4M

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.85

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLW
SGHT
Founded
1926
2011
Country
United States
United States
Employees
3710
N/A
Industry
Paper
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.4M
235.0M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
CLW
SGHT
Price
$13.64
$4.85
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$20.33
$9.08
AVG Volume (30 Days)
186.0K
331.1K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
$1,555,400,000.00
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
$4.16
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
12.42
N/A
52 Week Low
$11.73
$3.11
52 Week High
$30.96
$9.24

Technical Indicators

Market Signals
Indicator
CLW
SGHT
Relative Strength Index (RSI) 45.86 56.02
Support Level $12.09 $3.29
Resistance Level $14.56 $5.46
Average True Range (ATR) 0.74 0.41
MACD -0.00 0.03
Stochastic Oscillator 64.31 55.88

Price Performance

Historical Comparison
CLW
SGHT

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: